Abstract
In order to enhance the sensitivity and to develop a faster direct method for plasma and urine quantification of racemic ketorolac, its metabolites (p-hydroxy-ketorolac and ketorolac glucuronides) and ketorolac enantiomers, we developed an extraction procedure based on solid-phase extraction combined with specific and fast chromatographic separation. Extraction and chromatography resulted in cleaner chromatograms without interfering compounds. In both plasma and urine, linearity of the standard curves for racemic ketorolac and p-hydroxy-ketorolac was validated in the concentration range 0.025–10 mg L−1, while for ketorolac enantiomers in the concentration range 0.025–5 mg L−1. The lower limit of quantification was two times lower than in earlier described methods. The developed method was suitable for direct quantification of racemic ketorolac, p-hydroxy-ketorolac and ketorolac enantiomers in plasma and urine samples in women at delivery and in postpartum, enabling us to document significant intra-individual differences in pharmacokinetics between these physiological states.
Similar content being viewed by others
References
Brocks DR, Jamali F (1992) Clin Pharmacokinet 23:415–427
Mroszczak EJ, Lee FW, Combs D, Sarnquist FH, Huang BL, Wu AT, Tokes LG, Maddox ML, Cho DK (1987) Drug Metab Dispos 15:618–626
Mroszczak EJ, Jung D, Yee J, Bynum L, Sevelius H, Massey I (1990) Pharmacotherapy 10:33S–39S
Kulo A, van de Velde M, van Calsteren K, Smits A, de Hoon J, Verbesselt R, Deprest J, Allegaert K (2012) Int J Obstet Anesth 21:334–338
Kulo A, Peeters MY, Allegaert K, Smits A, de Hoon J, Verbesselt R, Lewi L, van de Velde M, Knibbe CA (2013) Br J Clin Pharmacol 75:850–860
Wu CL, Raja SN (2011) Lancet 377:2215–2225
McDonnell NJ, Keating ML, Muchatuta NA, Pavy TJ, Paech MJ (2009) Anaesth Intensive Care 37:539–551
Pan PH (2006) Int J Obstet Anesth 15:185–188
White PF, Raeder J, Kehlet H (2012) Anesth Analg 114:250–254
Pavy TJ, Paech MJ, Evans S (2001) Anesth Analg 92:1010–1014
Dahl V, Hagen IE, Sveen AM, Norseng H, Koss KS, Steen T (2002) Int J Obstet Anesth 11:91–94
De Oliveira GS, Jr Agarwal D, Benzon HT (2012) Anesth Analg 114:424–433
Kulo A, Hendrickx S, de Hoon J, Mulabegovic N, van Calsteren K, Verbesselt R, Allegaert K (2013) Eur J Drug Metab Pharmacokinet 38:1–4
Allegaert K, van Calsteren K, Hendrickx S, Kelchtermans J, Smits A, Kulo A, van de Velde M (2012) Acta Anaesthesiol Belg 63:121–125
Kulo A, van Calsteren K, Verbesselt R, Smits A, Devlieger R, de Hoon J, Allegaert K (2012) J Biomed Biotechnol 2012:437639
Xu F, Xu G, Shang B, Yu F (2009) Chromatographia 69:1421–1426
Flores-Murrieta FJ, Granados-Soto V, Hong E (1994) Boll Chim Farm 133:588–591
Wu AT, Massey IJ (1990) J Chromatogr 534:241–246
Wang Z, Dsida RM, Avram MJ (2001) J Chromatogr B Biomed Sci Appl 755:383–386
Kauffman RE, Lieh-Lai MW, Uy HG, Aravind MK (1999) Clin Pharmacol Ther 65:382–388
Mroszczak EJ, Ling T, Yee J, Massey I, Sevelius H (1985) Clin Pharmacol Ther 37:215
Hamunen K, Maunuksela EL, Sarvela J, Bullingham RES, Olkkola KT (1999) Acta Anaesthesiol Scand 43:1041–1046
Solà J, Pruñonosa J, Colom H, Peraire C, Obach R (1996) J Liq Chromatogr Relat Technol 19:89–99
Franceschi L, D’aronco S, Furlanut M (2010) J Bioanal Biomed 2:121–124
Campanero MA, López-Ocáriz AA, García-Quetglas E, Sádaba B, Azanza JR (1998) Chromatographia 48:203–208
Jones DJ, Bjorksten AR (1994) J Chromatogr B Biomed Appl 661:165–167
Mills MH, Mather LE, Gu XS, Huang JL (1994) J Chromatogr B Biomed Appl 658:177–182
Hayball PJ, Wrobel J, Tamblyn JG, Nation RL (1994) Br J Clin Pharmacol 37:75–78
Tsina I, Tam YL, Boyd A, Rocha C, Massey I, Tarnowski T (1996) J Pharm Biomed Anal 15:403–417
Nagilla R, Deshmukh DD, Duran SH, Ravis WR (2007) J Vet Pharmacol Ther 30:437–442
Diaz-Perez MJ, Chen JC, Aubry AF, Wainer IW (1994) Chirality 6:283–289
Patri S, Patni AK, Iyer SS, Khuroo AH, Monif T, Rana S, Kumar S, Jain R (2011) Chromatogr Res Int. doi:10.4061/2011/214793
Guidance for Industry: Bioanalytical Method Validation; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), BP (2001). Available at http://www.fda.gov/cvm
Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A (2000) Pharm Res 17:1551–1557
Rosing H, Man WY, Doyle E, Bult A, Beijnen JH (2000) J Liq Chromatogr Relat Technol 23:329–354
Kelm GR, Buchanan W, Meredith MP, Offenbacher S, Mankodi SM, Dobrozsi DJ, Bapat NV, Collins JG, Wehmeyer KR, Eichhold TH, Doyle MJ (1996) J Pharm Sci 85:842–847
Nagilla R, Deshmukh DD, Copedge KJ, Miller S, Martin B, Bell EC, Duran SH, Ravis WR (2009) J Vet Pharmacol Ther 32:49–55
Mroszczak E, Combs D, Chaplin M, Tsina I, Tarnowski T, Rocha C, Tam Y, Boyd A, Young J, Depass L (1996) J Clin Pharmacol 36:521–539
Lynn AM, Bradford H, Kantor ED, Andrew M, Vicini P, Anderson GD (2011) Paediatr Anaesth 21:325–334
Acknowledgments
The clinical research of Karel Allegaert is supported by the Fund for Scientific Research, Flanders (Belgium) (F.W.O. Vlaanderen) by a Fundamental Clinical Investigatorship (1800214 N), and of Aida Kulo by a JoinEU-SEE scholarship (2009–2010). We would like to thank Sonia Demarsin for her technical assistance. The clinical research was in part supported by an unrestricted grant provided by the Belgian Society for Anesthesia and Resuscitation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kulo, A., Mulabegovic, N., Loga-Zec, S. et al. Determination of Racemic Ketorolac, Ketorolac Enantiomers and Their Metabolites in Human Plasma and Urine by LC–UV, Applied in Clinical Study During and After Pregnancy. Chromatographia 77, 803–812 (2014). https://doi.org/10.1007/s10337-014-2670-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-014-2670-4